MedImmune confirms $6.5 million research deal with Johns Hopkins

12/13/2013 | Genetic Engineering & Biotechnology News

Baltimore-based Johns Hopkins University has signed a deal with AstraZeneca's research and development arm MedImmune to collaborate on research projects in cancer; respiratory conditions, inflammation and autoimmunity; infectious disease; antibody development and protein engineering.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ